Product Information
ARISTADA INITIO ER 675 MG/2.4 is a brand product labeled by Alkermes, Inc., priced at $1026.9112 per ML under NDC 65757050003. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
675 mg/2.4mL
Manufacturer
Alkermes, Inc.NDC
65757050003
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Last Updated
1/1/2026
Active Ingredients
ARIPIPRAZOLE LAUROXILApproval Type
New Drug (NDA)
FDA Application
NDA209830On Market Since
6/29/2018
Pharmacological Classes
Price Statistics
The NADAC for ARISTADA INITIO ER 675 MG/2.4 has been published 88 times since Oct 23, 2024, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1026.9112 per ML |
|---|---|
| All-time high | $1026.9112 (Jun 24, 2026) |
| All-time low | $936.4222 (Oct 23, 2024) |
| 52-week high | $1026.9112 |
| 52-week low | $967.7065 |
| Median price | $967.7065 |
| Average price | $980.0973 |
| Largest weekly change | +6.0% (Jan 14, 2026) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the aripiprazole lauroxil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARISTADA INITIO ER 675 MG/2.4?
The current National Average Drug Acquisition Cost (NADAC) for ARISTADA INITIO ER 675 MG/2.4, manufactured by Alkermes, Inc., is $1026.9112 per ML (NDC 65757050003), effective Jun 24, 2026.
How has the price of ARISTADA INITIO ER 675 MG/2.4 changed over time?
Over the history we have for it, the NADAC for ARISTADA INITIO ER 675 MG/2.4 has risen 9.7%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for ARISTADA INITIO ER 675 MG/2.4?
Since Oct 23, 2024, the NADAC for ARISTADA INITIO ER 675 MG/2.4 has ranged from a low of $936.4222 (Oct 23, 2024) to a high of $1026.9112 (Jun 24, 2026), with a median of $967.7065 per ML.
Are there cheaper alternatives to ARISTADA INITIO ER 675 MG/2.4?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARISTADA INITIO ER 675 MG/2.4, so no direct lower-cost alternative is listed.
Who manufactures ARISTADA INITIO ER 675 MG/2.4?
ARISTADA INITIO ER 675 MG/2.4 (NDC 65757050003) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification